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Abstract
Background: The changes in the renal function leading to a reduction of medullary blood flow can have a great
impact on sodium and water homeostasis and on the long-term control of arterial blood pressure. The RNA-Seq
approach was used for transcriptome profiling of the renal medulla from hypertensive ISIAH and normotensive
WAG rats to uncover the genetic basis of the changes underlying the renal medulla function in the ISIAH rats being
a model of the stress-sensitive arterial hypertension and to reveal the genes which possibly may contribute to the
alterations in medullary blood flow.
Results: Multiple DEGs specifying the function of renal medulla in ISIAH rats were revealed. The group of DEGs
described by Gene Ontology term ‘oxidation reduction’ was the most significantly enriched one. The other groups
of DEGs related to response to external stimulus, response to hormone (endogenous) stimulus, response to stress,
and homeostatic process provide the molecular basis for integrated responses to homeostasis disturbances in the
renal medulla of the ISIAH rats. Several DEGs, which may modulate the renal medulla blood flow, were detected.
The reduced transcription of Nos3 pointed to the possible reduction of the blood flow in the renal medulla
of ISIAH rats.
Conclusions: The generated data may be useful for comparison with those from different models of
hypertension and for identifying the common molecular determinants contributing to disease manifestation,
which may be potentially used as new pharmacological targets.
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Background
The study of molecular-genetic mechanisms of hyper-
tension is an important task for biology and medicine.
Multifactorial etiology of hypertension complicates the
solution of this problem, and despite of numerous
studies, the basal molecular mechanisms of essential
hypertension remain not fully elucidated. However, it
has long been known that renal dysfunction underlies
the development of all forms of hypertension in experi-
mental animals and humans [1–4].
The ISIAH (Inherited Stress-Induced Arterial Hyper-
tension) rat strain was developed to study the genetic
background of the stress-sensitive form of arterial hyper-
tension and its complications. Selection of the ISIAH
rats from an outbred Wistar stock was performed for a
systolic arterial blood pressure (BP) elevation induced by
0.5 h emotional stress, which was caused by keeping the
rats restricted in a small wire mesh cage. The ISIAH rats
acquire the elevated basal systolic arterial BP at the age
of 6 weeks (175.0 ± 3.5 mmHg in males and 165.0 ±
3.0 mmHg in females) and systolic arterial BP in these
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rats dramatically increases under the restriction condi-
tions [5, 6]. The development of the hypertensive state
in ISIAH rats is also accompanied by a hypertrophy of
the left ventricle, increase in the wall thickness of the
small arteries, and changes in the electrocardiographic
pattern [6]. The studies on the kidney histology showed
the alterations, which were indicative of an increase in
filtration barrier functional load and of processes leading
to the development of glomerular [7] and medullary
sclerosis in ISIAH rats [8].
The unraveling of the genetic basis of the renal func-
tion in ISIAH rats may be useful for understanding the
mechanisms underlying the stress-sensitive hypertension
development and for identifying the molecular determi-
nants, which may be potentially used as the therapeutic
targets for pharmacological intervention.
Recently, using the next-generation RNA sequencing
(RNA-Seq) approach, we analyzed the renal cortex tran-
scriptome in ISIAH rats [9]. The results of this study
showed that the functioning of the renal cortex in ISIAH
rats is based on the changes in transcriptional activity of
multiple genes related to different biological processes
and metabolic pathways. However, in a number of stud-
ies it was demonstrated that the initial changes leading
to the pathology of renal function begin from medullary
blood flow reduction, and these changes may exert sig-
nificant effects on sodium and water homeostasis and
on the long-term control of arterial BP [2, 10, 11].
Thus, the goal of the current study was to uncover the
genetic basis of the changes underlying the renal
medulla function in the ISIAH rats and to reveal the
features which possibly may be related to the alterations
in medullary blood flow. To achieve this goal the RNA-
Seq approach was used for transcriptome profiling of
the renal medulla from hypertensive ISIAH and normo-
tensive WAG rats. The differentially expressed genes
(DEGs) related to stress-sensitive hypertension and pos-
sibly to the alterations in medullary blood flow as well as
the metabolic pathways contributing to the inter-strain
differences in renal medulla functions were detected.
Several DEGs, which may modulate the renal medulla
blood flow, were identified and their possible impact on
the process was discussed.
Results
The expression of 13,646 genes was detected in the renal
medulla of analyzed rats. The comparative analysis of
their expression in the renal medulla of ISIAH and
WAG rats revealed 960 DEGs (listed in the Additional
file 1). The Additional file 2 represents the heatmap for
the DEGs. Approximately a half of these genes (524
genes, i.e., 54.7%) were down-regulated in the renal
medulla of ISIAH rats. The expression of 11 genes was
detected in renal medulla of only one rat strain
(Additional file 3). One of these genes (Retn, resistin) is
known as associated with hypertension. Its expression
was detected in renal medulla of ISIAH rats but not in
WAG. The list of the top 40 genes with the highest dif-
ferences in their expression in renal medulla of ISIAH
and WAG rats included two genes (Acsm3, acyl-CoA
synthetase medium-chain family member 3; and Ephx2,
epoxide hydrolase 2, cytoplasmic), which were annotated
in Rat Genome Database (RGD) as genes related to
hypertension (Table 1).
The genes making the strongest contribution to the
inter-strain differences were detected by the partial-least
squares discriminant analysis (PLS-DA). The distances
between ISIAH and WAG rats are shown in Fig. 1a, and
the results of the correlation analysis between gene
expression and PLS-DA Axis 1 are presented in Fig. 1b.
The DEGs are shown in red in Fig. 1b. The DEGs in the
most polar position contribute the most to the inter-
strain variations. The correlation coefficients for Acsm3
and Ephx2 were 0.996 and 0.994, correspondingly.
Hence, Acsm3 and Ephx2 may be considered as genes
making the strongest contribution to the inter-strain
differences. The differential expression of these and
several other genes was validated by real-time PCR
(Fig. 2). The correlation between the gene expression
estimated by two methods (RNA-Seq and real-time
PCR) was 0.99 (Fig. 3).
According to the RGD annotations, 58 DEGs found in
the current study are associated with hypertension
(Table 2). Seven of them (Agtr1a, Fn1, Gja1, Lama2,
Mmp2, Mmp9, Nos3) are known as being associated
with renal hypertension. The functional annotation in
Database for Annotation, Visualization and Integrated
Discovery (DAVID) additionally revealed four DEGs
(Col1a2, Guca2b, P2rx4, Pcsk5) related to BP regulation.
The transcription of most of genes associated with
hypertension (67.2%) was reduced in the renal medulla
of ISIAH rats. About a half of the DEGs related to
hypertension are also known as associated with diabetic
nephropathy and insulin resistance, and two DEGs were
found to be related to nephrosclerosis (Table 2). Many
of DEGs listed in the Table 2 are related to the diseases
of immune system. The study revealed 76 DEGs referred
to in RGD as associated with different renal diseases,
such as renal insufficiency, nephrosclerosis, diabetic
nephropathy, and renal fibrosis (Table 3).
The differential transcription of 59 transcription factor
genes was found in the renal medulla of ISIAH and
WAG rats (Table 4). No one of these genes is currently
referred to in databases as associated with arterial
hypertension or kidney diseases.
Gene Ontology (GO) terms for biological processes
defined as significantly enriched within the analysis in
DAVID are represented in Additional file 4. GO terms
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Table 1 Top 40 genes with the greatest difference in expression between ISIAH and WAG renal medulla
Gene symbol NCBI gene ID Gene definition log2 (fold_change)
ISIAH/WAG
LOC102546948 102546948 uncharacterized LOC102546948 −5.73
Galnt13 311039 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13
(GalNAc-T13)
−5.56
Pdilt 293544 protein disulfide isomerase-like, testis expressed −5.17
LOC501110 501110 similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon) (GSTA1-1)
(GST class-alpha)
−4.59
Slc10a2 29500 solute carrier family 10 (sodium/bile acid cotransporter), member 2 −4.40
Pcdh9 306091 protocadherin 9 −4.23
LOC100909561 100909561 nuclease-sensitive element-binding protein 1-like −3.74
Car5a 54233 carbonic anhydrase 5a, mitochondrial −3.74
LOC100361907 100361907 complement factor H-related protein B −3.73
Sphkap 316561 SPHK1 interactor, AKAP domain containing −3.65
LOC102552001 102552001 uncharacterized LOC102552001 −3.62
LOC102550987 102550987 uncharacterized LOC102550987 −3.57
Kcnj5 29713 potassium inwardly-rectifying channel, subfamily J, member 5 −3.23
Upk2 689093 uroplakin 2 3.12
LOC102555352 102555352 uncharacterized LOC102555352 3.13
LOC102551856 102551856 uncharacterized LOC102551856 3.21
Spta1 289257 spectrin, alpha, erythrocytic 1 (elliptocytosis 2) 3.28
LOC686967 686967 similar to olfactory receptor 1442 3.34
Acsm3a 24763 acyl-CoA synthetase medium-chain family member 3 3.40
LOC100911960 100911960 UDP-glucuronosyltransferase 1-9-like 3.44
Thrsp 25357 thyroid hormone responsive 3.51
Sprr1a 499660 small proline-rich protein 1A 3.51
Hpgd 79242 hydroxyprostaglandin dehydrogenase 15 (NAD) 3.52
LOC102553290 102553290 collagen alpha-1(III) chain-like 3.62
Ly6al 362935 lymphocyte antigen 6 complex, locus A-like 3.65
Akr1b8 286921 aldo-keto reductase family 1, member B8 3.70
Shisa3 498356 shisa family member 3 3.83
Nefh 24587 neurofilament, heavy polypeptide 3.90
Tcerg1l 361669 transcription elongation regulator 1-like 4.09
Krt19 360626 keratin 19 4.18
Ephx2a 65030 epoxide hydrolase 2, cytoplasmic 4.52
Ubd 29168 ubiquitin D 4.61
Resp18 50561 regulated endocrine-specific protein 18 4.65
Serpinb12 304692 serpin peptidase inhibitor, clade B (ovalbumin), member 12 5.38
Car3 54232 carbonic anhydrase 3 5.54
Fam111a 499322 family with sequence similarity 111, member A 5.86
LOC100362069 100362069 ribosomal protein L28-like 6.11
Gys2 25623 glycogen synthase 2 6.38
Stk32c 365381 serine/threonine kinase 32C 6.41
RGD1565131 498143 60S ribosomal protein L15-like 8.94
aGenes are annotated in Rat Genome Database (http://rgd.mcw.edu/) as associated with hypertension. ISIAH and WAG – rat strains used in the study
The Author(s) BMC Genetics 2016, 17(Suppl 3):151 Page 157 of 191
which might be essential for stress-sensitive hyperten-
sion development in ISIAH rats are shown in bold in
this file, and the details for DEGs from these groups are
given in Additional file 5.
The most significantly enriched GO terms were those
related to oxidation reduction, lipid metabolic process,
response to external stimulus as well as regulation of re-
sponse to external stimuli. The analysis showed that the
differences in renal medulla function between ISIAH
and WAG rats are under control of many genes partici-
pating in response to hormone stimulus including genes
associated with response to steroid (glucocorticoid)
hormone stimulus.
Multiple DEGs were related to transport, (including
sodium ion transport, water transport, glucose transport,
lipid transport) and regulation of transport. Many DEGs
associated with transport are annotated also as respon-
sible for homeostatic process, including ion homeostasis.
Several GO terms were related to BP control. These
were the groups of DEGs associated with blood circu-
lation, regulation of BP, and negative regulation of
blood coagulation.
Two large groups of DEGs were associated with re-
sponse to stress and regulation of response to stress.
The specificity of the stress types was defined by GO
terms related to responses to oxidative stress, to osmotic
stress, and to salt stress.
The other processes which might be involved in hyper-
tension development in ISIAH rats were: neurogenesis,
regulation of action potential in neuron, angiogenesis,
regulation of smooth muscle cell differentiation, cell ad-
hesion and regulation of cell adhesion.
Fig. 1 a Axes maximizing the distances between ISIAH and WAG rats. b The distribution of expressed genes along the first axis. The data are
based on the Pearson correlation coefficients between the first axis and the level of genes expression
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The functional annotation underlined the important
role of the immune system process and its regulation.
The analysis in the Kyoto Encyclopedia of Genes and
Genomes Pathway Database (KEGG) performed within
the DAVID highlighted sixteen pathways that were
significantly (p < 0.05) enriched (Additional file 6).
Several of them were also related to immune system
functioning. All of the pathways contained genes anno-
tated in RGD as associated with hypertension or with
kidney diseases.
Discussion
The transcriptome profiling of the renal medulla from
ISIAH and WAG rats let to identify multiple DEGs and
several metabolic pathways contributing to differences
between the renal medulla functions in ISIAH rats with
stress-sensitive hypertension and normotensive controls.
The functional annotation of DEGs within the analysis
in Databases demonstrated that many of them are asso-
ciated with hypertension and regulation of BP. One of
these, Retn, was expressed in renal medulla of hyperten-
sive rats but not in controls. However, the low level of
expression of this gene was reported in kidney from Fi-
scher 344 male rats, too [12]. So, the inter-strain differ-
ences in transcriptional activity of Retn shouldn’t be
essential for hypertension development in ISIAH rats.
In recent years, it has become clear that a key deter-
minant of the set point of the renal pressure-natriuresis
curve is the balance of reactive oxygen and nitrogen
species within the renal medullary region [11]. The ex-
perimentally induced elevations of either superoxide or
hydrogen peroxide in the renal medulla result in reduc-
tion of medullary blood flow, enhanced sodium re-
absorption, and hypertension [13].
In the current study, the group of DEGs described by
GO term ‘oxidation reduction’ was the most significantly
enriched one (Additional file 5). This group contained
several genes associated with hypertension and some of
them (Cyp1a1, cytochrome P450, family 1, subfamily a,
polypeptide 1; Cyp4f1, cytochrome P450, family 4,
subfamily f, polypeptide 1; Nos3, nitric oxide synthase
3, endothelial cell; Nox4, NADPH oxidase 4, Sod3,
superoxide dismutase 3, extracellular) are known as
involved in modulation of vascular tone and renal
tubular function.
Cyp1a1 knockout mice are hypertensive. Cyp1a1 me-
tabolizes omega-3 polyunsaturated fatty acids to vasodi-
lators and the loss of these vasodilators may lead to
increases in BP [14]. CYP1A1 contributes to eNOS
(same as Nos3) activation, nitric oxide (NO) bioavailabil-
ity, and NO-dependent BP regulation [15]. So, the de-
creased level of Cyp1a1 transcription in ISIAH renal
medulla suggests its contribution to hypertension devel-
opment in ISIAH rats.
CYP4F1 was characterized as the most critical 4 F
isoform involved in the production of 20-
hydroxyeicosatetraenoic acid (20-HETE), a potent ei-
cosanoid that modulates vascular tone and renal
tubular function [16]. 20-HETE has been shown to
play a complex role in BP regulation. In the kidney
tubules, 20-HETE inhibits sodium reabsorption and
promotes natriuresis, thus, contributing to antihyper-
tensive mechanisms. In contrast, in the microvascu-
lature, 20-HETE plays a pressor role by sensitizing
smooth muscle cells to constrictor stimuli and increasing
vascular myogenic tone, and by acting on the endothelium
to further promote endothelial dysfunction and endothe-
lial activation. In addition, 20-HETE induces endothelial
angiotensin-converting enzyme, thus, setting forth a
potential feed forward prohypertensive mechanism by
Fig. 2 The relative mRNA abundance measured by qPCR. The
normalized mRNA level in control samples of the WAG rats was
assigned a value of 1. Vertical bars show the standard error of the
mean, and significance of inter-strain difference is indicated by
*p < 0.05, **p < 0.01, ***p < 0.001
Fig. 3 Comparison of gene expression level measurements obtained
by RNA-seq and qPCR
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Table 2 Genes differentially expressed in ISIAH and WAG renal medulla and referred to in Databases as associated with
hypertension and blood pressure regulation
Gene symbol NCBI gene ID Gene name log2 fold_change ISIAH/WAG
Rat Genome Database
Acsm3e 24763 acyl-CoA synthetase medium-chain family member 3 3.40
Adipoqc,d,e 246253 adiponectin, C1Q and collagen domain containing 1.17
Adra1bc 24173 adrenoceptor alpha 1B −1.31
Adra2a 25083 adrenoceptor alpha 2° −1.15
Agtr1aa,c,d,e 24180 angiotensin II receptor, type 1° −0.47
Alas1 65155 aminolevulinate, delta-, synthase 1 0.74
Angpt2e 89805 angiopoietin 2 −0.79
Aqp2d 25386 aquaporin 2 (collecting duct) −0.47
Aqp4e 25293 aquaporin 4 −0.59
Clud,e 24854 clusterin, transcript variant X1 −0.80
Cnr1c 25248 cannabinoid receptor 1 (brain) −0.58
Comt 24267 catechol-O-methyltransferase −0.67
Corin 289596 corin, serine peptidase −1.04
Cst3c,d,e 25307 cystatin C −0.50
Cyp1a1e 24296 cytochrome P450, family 1, subfamily a, polypeptide 1 −0.51
Cyp4f1 56266 cytochrome P450, family 4, subfamily f, polypeptide 1 0.60
Dio2c 65162 deiodinase, iodothyronine, type II −2.56
Dusp1e 114856 dual specificity phosphatase 1 −0.71
Ebag9 299864 estrogen receptor binding site associated, antigen, 9 0.49
Emilin1 298845 elastin microfibril interfacer 1 −0.65
Ephx1e 25315 epoxide hydrolase 1, microsomal (xenobiotic) 0.70
Ephx2c,d 65030 epoxide hydrolase 2, cytoplasmic 4.52
F2d, e 29251 coagulation factor II −0.93
Fbn1d 83727 fibrillin 1, transcript variant X1 −0.61
Fn1a,d,e 25661 fibronectin 1 −0.98
Gja1a,e 24392 gap junction protein, alpha 1 0.99
Gstm2 24424 glutathione S-transferase mu 2 −0.76
Gstp1e 24426 glutathione S-transferase pi 1 0.53
Hgfc,d,e 24446 hepatocyte growth factor −0.77
Hsd17b4e 79244 hydroxysteroid (17-beta) dehydrogenase 4 0.52
Igf1d,e 24482 insulin-like growth factor 1 −0.75
Itgavc 296456 integrin, alpha V −0.60
Lama2a 309368 laminin, alpha 2 −0.58
Lox 24914 lysyl oxidase −0.81
Mifc,e 81683 macrophage migration inhibitory factor (glycosylation-inhibiting factor) 0.55
Mmp2a,e 81686 matrix metallopeptidase 2 −0.54
Mmp9ad,e 81687 matrix metallopeptidase 9 −2.00
Mthfrb,d,e 362657 methylenetetrahydrofolate reductase (NAD(P)H) 0.49
Nos3a,c,d,e 24600 nitric oxide synthase 3, endothelial cell −0.55
Nox4d 85431 NADPH oxidase 4 0.50
Pappa 313262 pregnancy-associated plasma protein A −0.68
Pecam1d,e 29583 platelet/endothelial cell adhesion molecule 1 −0.45
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stimulating the renin-angiotensin-aldosterone system
(RAAS) [17].
Nox4 is a hydrogen peroxide-producing NADPH oxi-
dase isoform highly expressed in the kidney. NAD(P)H
oxidase was recognized as the major source of reactive
oxygen species (ROS) contributing to salt-induced
hypertension [18]. Dahl salt-sensitive hypertensive rats
with knockout of Nox4 exhibited a reduced renal injury
and attenuated BP response to high salt [19]. Thus, we
may suggest that the increased transcription of Nox4 in
the renal medulla of ISIAH rats may contribute to
increased rate of ROS production and hypertension
development.
Superoxide dismutases (SODs) convert superoxide to
hydrogen peroxide, which is then removed by glutathi-
one peroxidase or catalase [20]. The oxidative stress ap-
pears to be a common feature of hypertensive disorders
from diverse origins [21], and it has been long known
that oxidative stress induces or enhances the activity of
SODs [22]. Thus, the enhanced expression of Sod3 pro-
vides a rationale to suggest the presence of the oxidative
stress in the renal medulla of ISIAH rats which may
require the enhanced activity of SOD3 to prevent the
formation of highly aggressive ROS.
Nos3 is known as related to the diversity of biological
processes. In the current research, Nos3 was related to
GO term groups such as regulation of BP, oxidation re-
duction, response to stress and to steroid hormone
stimulus, regulation of calcium and sodium ion trans-
port, and angiogenesis (Additional file 5). Endothelial ni-
tric oxide synthase (eNOS; NOS3) is physiologically
important for vascular homeostasis [23]. It is expressed
predominantly in the endothelium of blood vessels
where it catalyzes the production of NO. NO regulates
vascular tone and local blood flow, platelet aggregation
and adhesion, and leukocyte-endothelial cell interac-
tions. Abnormalities in NO production by the vascular
endothelium result in endothelial dysfunction, which oc-
curs in hypertension, diabetes, aging, and as a prelude to
atherosclerosis [24].
Nos3 transcription was found to be reduced in the
renal medulla of ISIAH rats. The reduced eNOS expres-
sion was earlier reported for different models of hyper-
tension: spontaneously hypertensive rats (SHR) [25],
Table 2 Genes differentially expressed in ISIAH and WAG renal medulla and referred to in Databases as associated with
hypertension and blood pressure regulation (Continued)
Ptgdsb,c,d 25526 prostaglandin D2 synthase (brain) −0.78
Ptk2bc,e 50646 protein tyrosine kinase 2 beta −0.79
Retnc,d,e 246250 resistin expression was detected only
in ISIAH rats
Rnpep 81761 arginyl aminopeptidase (aminopeptidase B) −0.47
RT1-Bbe 309622 RT1 class II, locus Bb −1.26
Serpine2 29366 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1),
member 2
−0.55
Slc26a4 29440 solute carrier family 26 (anion exchanger), member 4 0.59
Slc2a4c 25139 solute carrier family 2 (facilitated glucose transporter), member 4 −0.76
Slc5a2 64522 solute carrier family 5 (sodium/glucose cotransporter), member 2 0.64
Slc6a19 664630 solute carrier family 6 (neutral amino acid transporter), member 19 0.48
Slc8a1 29715 solute carrier family 8 (sodium/calcium exchanger), member 1 0.53
Slc9a3r2 116501 solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member
3 regulator 2
−0.49
Sod3c,d 25352 superoxide dismutase 3, extracellular 0.56
Tacr3 24808 tachykinin receptor 3 −1.22
Tfc,d,e 24825 transferrin −1.43
Vcam1c,d,e 25361 vascular cell adhesion molecule 1 −0.86
DAVID
Col1a2e 84352 collagen, type I, alpha 2 −0.53
Guca2b 64055 guanylate cyclase activator 2B 2.03
P2rx4 29659 purinergic receptor P2X, ligand-gated ion channel 4 −1.41
Pcsk5 116548 proprotein convertase subtilisin/kexin type 5 0.73
ISIAH and WAG – rat strains used in the study. DAVID – Database for Annotation, Visualization and Integrated Discovery (http://david.abcc.ncifcrf.gov/)
Genes associated with: arenal hypertension; bnephrosclerosis; cinsulin resistance; ddiabetic nephropathy; eimmune system diseases
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Table 3 Genes differentially expressed in ISIAH versus WAG renal medulla and annotated in Rat Genome Database as associated
with kidney diseases
Gene symbol NCBI gene ID Gene name log2 fold change ISIAH/WAG
Acsm3 24763 acyl-CoA synthetase medium-chain family member 3 3.40
Adipoqc,d 246253 adiponectin, C1Q and collagen domain containing 1.17
Agtr1aa,c,d 24180 angiotensin II receptor, type 1a −0.47
Ak4c 29223 adenylate kinase 4 0.63
Alpl 25586 alkaline phosphatase, liver/bone/kidney 0.53
Amacr 25284 alpha-methylacyl-CoA racemase 0.50
Angpt2a 89805 angiopoietin 2 −0.79
Anxa2 56611 annexin A2 −0.45
Apohd 287774 apolipoprotein H (beta-2-glycoprotein I) −1.52
Aqp2d 25386 aquaporin 2 (collecting duct) −0.47
Baat 29725 bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) 0.78
Car2 54231 carbonic anhydrase 2 0.53
Cftr 24255 cystic fibrosis transmembrane conductance regulator −1.22
Cldn19 298487 claudin 19 −0.53
Clua,c,d 24854 clusterin −0.80
Col3a1a,c 84032 collagen, type III, alpha 1 −0.64
Col4a5 363457 collagen, type IV, alpha 5 −0.45
Comt 24267 catechol-O-methyltransferase −0.67
Csf1rc,d 307403 colony stimulating factor 1 receptor −0.73
Cst3d 25307 cystatin C −0.50
Cubnd 80848 cubilin (intrinsic factor-cobalamin receptor) 0.68
Cyp1a1c 24296 cytochrome P450, family 1, subfamily a, polypeptide 1 −0.51
Cyp4a3 298423 cytochrome P450, family 4, subfamily a, polypeptide 3 0.52
Dusp1 114856 dual specificity phosphatase 1 −0.71
Ebag9 299864 estrogen receptor binding site associated, antigen, 9 0.49
Ephx2c,d 65030 epoxide hydrolase 2, cytoplasmic 4.52
F2c,d 29251 coagulation factor II −0.93
Fbn1a,d 83727 fibrillin 1 −0.61
Fgac 361969 fibrinogen alpha chain 0.85
Fhit 60398 fragile histidine triad 1.58
Fmodd 64507 fibromodulin −1.09
Fn1a,c,d 25661 fibronectin 1 −0.98
Gatmc 81660 glycine amidinotransferase (L-arginine:glycine amidinotransferase) 0.86
Gja1 24392 gap junction protein, alpha 1 0.99
Gpc1 58920 glypican 1 −0.72
Gstp1c 24426 glutathione S-transferase pi 1 0.53
Gtpbp4c 114300 GTP binding protein 4 3.01
Hao1 311446 hydroxyacid oxidase (glycolate oxidase) 1 −1.60
Hgfd 24446 hepatocyte growth factor −0.77
Igf1d 24482 insulin-like growth factor 1 −0.75
Igfbp1d 25685 insulin-like growth factor binding protein 1 1.26
Il4r 25084 interleukin 4 receptor 0.64
Lama2 309368 laminin, alpha 2 −0.58
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Dahl salt-sensitive rats [26], two-kidney, one-clip hyper-
tensive rats [27]. The reduced level of eNOS and NO
production in the renal medulla is associated with a re-
duction in medullary blood flow and have considerable
importance in sodium and water homeostasis and the
long-term control of arterial pressure [27–29]. Recently,
the reduced renal blood flow measured by magnetic res-
onance angiography was reported in ISIAH rats as com-
pared to normotensive Wistar rats [30]. So, the reduced
transcription of the Nos3 in the renal medulla of ISIAH
rats may be considered as a key feature possibly leading
to the medullary blood flow reduction. This, and the de-
creased NO availability in serum of ISIAH rats and its
negative correlation with the BP reported earlier [31],
might indicate the impact of this mechanism on stress-
sensitive hypertension development.
One more gene which may participate in regulation of
NO availability in the renal medulla of ISIAH rats is
Ephx2 encoding the soluble epoxide hydrolase (sEH). In
the current study, Ephx2 was one of the DEGs
Table 3 Genes differentially expressed in ISIAH versus WAG renal medulla and annotated in Rat Genome Database as associated
with kidney diseases (Continued)
Lgals1 56646 lectin, galactoside-binding, soluble, 1 0.88
Lrp1a 299858 low density lipoprotein receptor-related protein 1 −0.53
Lrp5 293649 low density lipoprotein receptor-related protein 5 −0.47
Ltbp1 59107 latent transforming growth factor beta binding protein 1 −0.57
Mif 81683 macrophage migration inhibitory factor (glycosylation-inhibiting factor) 0.55
Mme 24590 membrane metallo-endopeptidase 1.35
Mmp2a, c 81686 matrix metallopeptidase 2 −0.54
Mmp9a, d 81687 matrix metallopeptidase 9 −2.00
Mok 362787 MOK protein kinase −0.93
Mthfrb, c, d 362657 methylenetetrahydrofolate reductase (NAD(P)H) 0.49
Nos3c, d 24600 nitric oxide synthase 3, endothelial cell −0.55
Nox4d 85431 NADPH oxidase 4 0.50
Nphs2a 170672 nephrosis 2, idiopathic, steroid-resistant 0.57
Pecam1d 29583 platelet/endothelial cell adhesion molecule 1 −0.45
Pla2g4a 24653 phospholipase A2, group IVA (cytosolic, calcium-dependent) −0.69
Ptgdsb, d 25526 prostaglandin D2 synthase (brain) −0.78
Ptk2b 50646 protein tyrosine kinase 2 beta −0.79
Rap1gapa 313644 Rap1 GTPase-activating protein −0.60
Retnc, d 246250 resistin expression was detected only
in ISIAH rats
RT1-Bb 309622 RT1 class II, locus Bb −1.26
Serpinf1d 287526 serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium
derived factor), member 1
−2.10
Serping1 295703 serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 0.56
Sfrp1 84402 secreted frizzled-related protein 1 −0.61
Slc17a2 306950 solute carrier family 17, member 2 0.59
Slc19a3c 316559 solute carrier family 19 (thiamine transporter), member 3 1.00
Slc5a2 64522 solute carrier family 5 (sodium/glucose cotransporter), member 2 0.64
Slc6a19 664630 solute carrier family 6 (neutral amino acid transporter), member 19 0.48
Slit2 360272 slit homolog 2 (Drosophila) 0.45
Sod3d 25352 superoxide dismutase 3, extracellular 0.56
Tfd 24825 transferrin −1.43
Timp2d 29543 TIMP metallopeptidase inhibitor 2 −0.52
Vcam1c,d 25361 vascular cell adhesion molecule 1 −0.86
Vtnd 29169 vitronectin −1.18
Genes associated with: arenal fibrosis; bnephrosclerosis; crenal insufficiency, ddiabetic nephropathy; ISIAH and WAG – rat strains used in the study
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Table 4 Transcription factor genes differentially expressed in ISIAH and WAG renal medulla
Gene symbol NCBI gene ID Gene name log2 fold_change ISIAH/WAG
Alx1 25401 ALX homeobox 1 −1.13
Arntl 29657 aryl hydrocarbon receptor nuclear translocator-like −1.01
Bcl6 303836 B-cell CLL/lymphoma 6 −2.02
Bcl6b 360551 B-cell CLL/lymphoma 6, member B −0.80
Bhlhe22 365748 basic helix-loop-helix family, member e22 −1.08
Bnc2 298189 basonuclin 2 0.61
Btbd11 314675 BTB (POZ) domain containing 11 −0.65
Ccrn4l 310395 CCR4 carbon catabolite repression 4-like (S, cerevisiae) 0.64
Cebpd 25695 CCAAT/enhancer binding protein (C/EBP), delta −0.83
Dab2 79128 disabled 2, mitogen-responsive phosphoprotein 0.49
Dmrt2 309430 doublesex and mab-3 related transcription factor 2 −0.55
Esrrb 299210 estrogen-related receptor beta −0.58
Etv5 303828 ets variant 5 −0.70
Fhl1 25177 four and a half LIM domains 1 1.09
Gcfc2 312474 GC-rich sequence DNA-binding factor 2 −0.61
Gne 114711 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase −0.51
Grhl1 313993 grainyhead-like 1 (Drosophila) 1.91
Hand2 64637 heart and neural crest derivatives expressed 2 expression was detected
only in ISIAH rats
Hes6 316626 hes family bHLH transcription factor 6 −0.72
Id3 25585 inhibitor of DNA binding 3 −0.50
Id4 291023 inhibitor of DNA binding 4 0.47
Ilf2 310612 interleukin enhancer binding factor 2 −0.46
Irf7 293624 interferon regulatory factor 7 0.59
Irf8 292060 interferon regulatory factor 8 −0.58
Khdrbs3 64015 KH domain containing, RNA binding, signal transduction associated 3 −1.23
Lmo2 362176 LIM domain only 2 −0.79
Map2 25595 microtubule-associated protein 2 −1.44
Mcm7 288532 minichromosome maintenance complex component 7 0.61
Mef2c 499497 myocyte enhancer factor 2C −0.59
Mybl1 297783 myeloblastosis oncogene-like 1 −0.56
Nfkbil1 361794 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 0.98
Notch3 56761 notch 3 −0.50
Npas2 316351 neuronal PAS domain protein 2 −0.90
Nr2f1 81808 nuclear receptor subfamily 2, group F, member 1 −1.31
Nrip3 361625 nuclear receptor interacting protein 3 −0.83
Osr1 298878 odd-skipped related transciption factor 1 −1.29
Osr2 315039 odd-skipped related transciption factor 2 1.17
P8 113900 nuclear proten 1 −0.95
Patz1 305471 POZ (BTB) and AT hook containing zinc finger 1 0.57
Paxbp1 681004 PAX3 and PAX7 binding protein 1 −0.53
Pou2af1 690528 POU class 2 associating factor 1 1.19
Prdm6 307305 PR domain containing 6 1.50
Prox1 305066 prospero homeobox 1 −1.06
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associated with hypertension and showing the highest
differences in expression in ISIAH and WAG renal me-
dulla. sEH metabolizes the epoxyeicosatrienoic acids
(EETs) having antihypertensive properties. EETs also
possess anti-inflammatory actions that could protect the
kidney vasculature from injury during renal and cardio-
vascular diseases [32]. It was shown that P450 eicosa-
noids are vasodilatory, largely through their ability to
activate eNOS and NO release [33]. sEH is a main ef-
fector of angiotensin II-induced hypertension [34].
Ephx2 was also recognized as a gatekeeper gene contrib-
uting to programmed hypertension [35]. In the current
study, the PLS regression method, which is commonly
used for biomarker selection in metabolomic [36] and
gene expression [37] studies, reckoned Ephx2 as one of
the genes making the most significant contribution to
the inter-strain differences. All this and the increased
transcription of Ephx2 found earlier in hypothalamus
[38] and renal cortex [9] of ISIAH rats prompt us to
consider Ephx2 as a key candidate for further studies of
the mechanisms underlying the stress-sensitive hyper-
tension in ISIAH rats. The sEH was already considered
as a suitable target for pharmaceutical intervention in
the hypertension treatment [39].
The other groups of DEGs, being among the most sig-
nificantly enriched and described by GO terms ‘response
to external stimulus’, ‘response to hormone (endogenous)
stimulus’, ‘response to stress’, and ‘homeostatic process’,
provide the molecular basis for integrated responses to
homeostasis disturbances in the renal medulla of the
ISIAH rats (Additional file 5). Most DEGs associated
with BP regulation (Adipoq, Adra1b, Agtr1a, Aqp2,
Ephx2, Guca2b, Mif, Nos3, P2rx4, Tacr3) were related to
these groups. As it may be seen from the following dis-
cussion, some of these genes may contribute to vascular
tone and renal blood flow regulation.
Adiponectin (Adipoq gene) stimulates production of
nitric oxide in vascular endothelial cells [40] and possess
anti-atherogenic properties [41]. The increased expres-
sion of Adipoq in renal medulla of ISIAH rats may be
protective against the reduction in medullary blood flow.
Agtr1a (angiotensin II receptor, type 1a) encodes the
receptor for angiotensin II, which is the main effector of
RAAS [42]. AT1A receptors expressed on the renal vas-
culature and/or renal tubular epithelia play a critical role
in sodium and volume homeostasis [43]. AGTR1a is re-
quired for mineralocorticoid receptor stimulation to in-
duce vascular remodeling, inflammation and endothelial
dysfunction [44]. It was shown that in the euvolemic
state the mean arterial pressure was significantly lower
in the AT1A receptor-deficient mice compared with
wild-type controls [45]. So, the reduced transcription of
Agtr1a in ISIAH renal medulla may be considered as a
compensatory mechanism against the complications
mentioned above.
The alpha1B-adrenoceptors (Adra1b) are involved in
blood vessel remodeling [46] and mediate the vasocon-
strictor actions of the renal sympathetic nerves in rats
with renal failure [47, 48]. Adra1b is one of the sympa-
thetic nervous system (SNS) components [49]. It is
known that increased renal SNS activity reduces urinary
sodium and water excretion, renal blood flow and
Table 4 Transcription factor genes differentially expressed in ISIAH and WAG renal medulla (Continued)
Sim1 309888 single-minded family bHLH transcription factor 1 −0.50
Smarcd3 296732 SWI/SNF related, matrix associated, actin dependent regulator of chromatin,
subfamily d, member 3
−0.58
Spry4 291610 sprouty homolog 4 (Drosophila) −0.61
Stat5a 24918 signal transducer and activator of transcription 5A 0.63
Tcerg1l 361669 transcription elongation regulator 1-like 4.09
Tcf21 252856 transcription factor 21 −0.48
Tcf4 84382 transcription factor 4 −0.66
Tle2 299636 transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) −0.61
Zbtb16 353227 zinc finger and BTB domain containing 16 −1.11
Zdhhc2 246326 zinc finger, DHHC-type containing 2 0.75
Zfhx2 305888 zinc finger homeobox 2 −0.88
Zfp189 313219 zinc finger protein 189 −0.62
Zfp354a 24522 zinc finger protein 354A 0.58
Zfp449 684901 zinc finger protein 449 −0.71
Zfp710 293044 zinc finger protein 710 −0.76
Zfp958 100302405 zinc finger protein 958 −0.64
ISIAH and WAG – rat strains used in the study
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glomerular filtration rate [49]. Thus, the reduced
transcription of Adra1b in ISIAH renal medulla may
be considered as a protective mechanism against the
excessive effects of SNS activation reported earlier in
ISIAH rats [50].
One more DEG, which may cause the differences in
SNS activity in ISIAH and WAG rats is Comt (catechol-
O-methyltransferase), which encodes the enzyme in-
volved in the degradation of catecholamines. The inhib-
ition of COMT induces dopamine-dependent natriuresis
[51]. The Comt-gene-disrupted mice were resistant to
salt-induced hypertension [52]. So, the decreased expres-
sion of Comt in the renal medulla of ISIAH rats may
lead to increase in renal dopaminergic effects and so-
dium excretion, and may be considered as an adaptive
or protective mechanism for control of hypertension
development in ISIAH rats. Earlier, the significantly
decreased transcription of Comt was also detected in
kidney of 6-month old ISIAH rats [53].
MIF (Macrophage migration inhibitory factor) pos-
sesses the ability to directly regulate the immunosup-
pressive actions of glucocorticoids and thus plays a
critical role in the host control of inflammation and im-
munity [54]. MIF is a key factor in atherogenesis [55,
56]. The upregulation of the podocyte-expressed MIF in-
duces an injury of podocytes and accelerates the pro-
gression of glomerulosclerosis [57]. In ISIAH rats, the
upregulation of Mif gene was found both in renal cortex
[9] and in renal medulla (the current study), and pos-
sibly may contribute to development of atherosclerosis
as well as to glomerulo- and medullary sclerosis histo-
logically determined earlier [7, 8].
The changes in expression of DEGs associated with
renal hypertension (Agtr1a, Fn1, Gja1, Lama2, Mmp2,
Mmp9, Nos3) may also be suggested to have a significant
impact on disease development in ISIAH rats (Table 2).
Fibronectin 1 is a glycoprotein involved in cell–matrix
and cell–cell adhesion [58]. Fibronectin 1 may be in-
duced by different agents including angiotensin II [59]
and aldosterone [44]. Both of these stimuli may lead to
vascular remodeling and vascular inflammation [44, 60].
So, the reduction in Fn1 expression may be directed
against the excessive vascular complications develop-
ment in ISIAH renal medulla. It is worth also to men-
tion that almost all (33 gene out of 37) of the multiple
DEGs related to GO terms ‘cell adhesion’ and ‘cell–
matrix adhesion’ were downregulated in ISIAH renal
medulla (Additional file 5), and it is of high probability
that those changes, at least in a part, are directed to-
wards the prevention of vascular complications.
The protein encoded by Gja1 (or Cx43, connexin 43)
is a component of gap junctions, which permit the pas-
sage of ions and chemical mediators from cell to cell
[61]. The expression of connexins in renal arterioles is
believed to have a profound impact on conducted re-
sponses, regulation of arteriolar tonus and renal blood
flow. Besides, the cell-to-cell communication mediated
by Cx43 channels may contribute to regulating the elas-
ticity of the vascular wall [62]. However, no evidence for
an increased abundance of Cx43 in renal arterioles of
SHR when compared with normotensive counterparts
was found [63]. In the ISIAH renal medulla the in-
creased transcriptional level of Gja1 was detected.
Earlier a differential regulation of aortic Cx43 in differ-
ent models of hypertension was reported [62], and this
may also be true for kidney. This may be one of the
features distinguishing the mechanism of hypertension
development in ISIAH rats from that in SHR.
LAMA2 is an extracellular matrix protein [64] in-
volved in regulation of cell adhesion. Matrix metallopro-
teinases (MMP2 and MMP9) belong to a family of
metalloendopeptidases that cleave the protein compo-
nents of the extracellular matrix and thereby play a
central role in tissue remodeling [65]. MMP2 (Mmp2)
and MMP9 (Mmp9) are involved in the vascular smooth
muscle cell activation and neointimal formation that
characterize arterial tissue remodeling after injury [66].
The overexpression of MMP9 and MMP2 have been ob-
served within plaques [67]. The elevated urine values of
MMP-9 was recognized as a marker of atherosclerotic
disease [68], and, alternatively, the loss of MMP9 re-
duces atherosclerotic burden [69]. MMP-2 also contrib-
utes to the development of atherosclerosis [70]. Taking
that into consideration, the decrease in Mmp2 and
Mmp9 expression may be considered as protective
against vascular remodeling in ISIAH renal medulla.
So, in ISIAH renal medulla, several DEGs associated
with renal hypertension are related to cell–matrix and
cell–cell adhesion processes. It is known that in hyper-
tension the increase in arterial stretch stimulates vessel
thickening to normalize the tensile forces. This process
requires modification of the extracellular matrix and of
cell–matrix interactions [71]. The results of the current
study are in a good agreement with this conception and
highlighted the major DEGs contributing to the modifi-
cation of the extracellular matrix and of cell–matrix in-
teractions in renal medulla of rats with stress-sensitive
hypertension.
Multiple genes with the changed level of transcription
related to ion transport and to regulation of ion trans-
port were found in the renal medulla of ISIAH rats.
Many of these genes should be essential for maintaining
the sodium and water balance in hypertensive state.
However, it is not possible to discuss the role of all the
DEGs contributing to these processes within the current
paper. We just would like to mention that all the pro-
cesses including such a basic one as sodium and water
balance may undergo the strain-specific regulation. This
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may be seen, for example, in the case of the Aqp2 being
regulated by vasopressin [72] and playing a role in body
water balance [73]. Mice with reduced expression of
Aqp2 have severe polyuria and very low urine osmolality
[74]. Aqp2 transcription was reduced in renal medulla of
ISIAH rats. The reduced AQP2 in the renal medulla was
reported earlier in the clipped kidney of rats with experi-
mental two-kidney, one clip hypertension [75] and in
Milan hypertensive rats [76]. However, the medullary ex-
pression of AQP2 protein was increased in DOCA-salt
hypertensive rats [77] and in SHR [78]. The existence of
the strain-specific differences in the molecular mecha-
nisms of the hypertension development points out the
importance of the search for the common features con-
tributing to disease manifestation which may be poten-
tially used as new pharmacological targets.
Conclusions
The current study helped to identify a number of DEGs
specifying the function of renal medulla in ISIAH rats
being a model of the stress-sensitive arterial hyperten-
sion. The genes already known as associated with hyper-
tension development were mostly discussed. However,
the other genes also may have indirect influence on dis-
ease development and maintenance. The discussion
demonstrated that the changes in expression of many
genes may be considered as protective or adaptive and
directed toward the integration and coordination of the
general homeostasis of the organism. Several DEGs,
which may modulate the renal medulla blood flow were
detected. The reduced transcription of the Nos3 points
to the possible reduction of the blood flow in the renal
medulla of ISIAH rats.
The generated data may be useful for comparison with
those from different models of hypertension and for
identifying the common molecular determinants con-
tributing to disease manifestation which may be poten-
tially used as new pharmacological targets. Based on
discussion, Ephx2 seems to be a promising candidate for
further studies of its potential as therapeutic target.
Methods
Animals
The hypertensive ISIAH/Icgn and normotensive WAG/
GSto-Icgn rat strains were used in the current study.
Rats were bred in the Center for Genetic Resources of
Laboratory Animals at the Institute of Cytology and
Genetics, Siberian Branch of the Russian Academy of
Sciences, (Novosibirsk, Russia, RFMEFI61914X0005 and
RFMEFI62114X0010). All rats were kept in standard la-
boratory conditions and had free access to food and
water. The 3-month old ISIAH, and WAG male rats
were used in RNA-seq experiments. Each group of
experimental animals contained 3 rats. Rats were
individually caged one week before the measurement of
the systolic arterial BP, which was measured indirectly
by the tail-cuff method as it was described earlier [9].
The mean systolic arterial BP was 171.7 ± 1.22 mmHg in
the experimental group of ISIAH males and 116.33 ±
1.86 mmHg in WAG. Six days after BP measurement,
rats were decapitated and their kidneys were rapidly
removed and sectioned. The samples of renal medulla
were stored in RNA Later (Qiagen, Chatsworth, CA)
at −70 °C until use. The animal experiments were
conducted with approval of the Institute’s Animal
Care and Use Committee.
RNA-seq analysis
The samples of renal medulla were sent to JSC Genoa-
nalytica (Moscow, Russia), where the technological
part of the RNA-seq analysis was conducted as it was
described earlier {9}. Dynabeads mRNA Purification
Kit (Ambion, USA) was used for mRNA extraction
and NEBNext mRNA Library Prep Reagent Set for
Illumina (NEB, USA) was used for cDNA libraries
construction. All kits were used according to the man-
ufacturer’s protocol. cDNA libraries were sequenced
using a HiSeq1500 Sequencing System (Illumina Se-
quencing, San Diego, USA) in a single end mode with
a read length of 50 bases. Three biological replicates
were analyzed for each rat strain. The sequencing data
were subjected to adapter trimming and low-quality
sequence removal and mapped to the rat reference
genome (RGSC Rnor_5.0, rn5) with the use of
Tophat2 [79]. Quality metrics of the mapped libraries
(Additional file 7) were collected using the Picard ‘Col-
lectRnaSeqMetrics’ tool (http://broadinstitute.github.io/
picard/). The differential expression analysis was per-
formed using the Cufflinks workflow [80]. A gene was de-
fined as being expressed if it matched the Cufflinks
criteria on suitability for statistical testing (test status
‘OK’). Genes with a Benjamini-Hochberg adjusted p-value
(q-value) <0.05 were considered to be differentially
expressed. Heatmap of the genes differentially expressed
(q value < 0.01) in the renal medulla of the ISIAH and
WAG rats was built using the core functions of R statis-
tical language (https://cran.r-project.org/); a hierarchical
‘complete linkage’ clustering by Euclidean distance was
used to construct the dendrograms. The raw RNA-Seq
data are available at the NCBI Short Read Archive data-
base under the Accession number: PRJNA299102.
Functional annotation
The DEGs were functionally annotated in DAVID (The
Database for Annotation, Visualization and Integrated
Discovery) (http://david.abcc.ncifcrf.gov/) [81, 82] with
the use of Rattus norvegicus genome as the background
list for the over-representation analysis. The significantly
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enriched biological processes (p < 0.05) were identified
using the Gene Ontology option. The most significant
to the data set pathways were identified in Kyoto
Encyclopedia of Genes and Genomes Pathway Database
(KEGG, http://www.genome.jp/kegg/). The annotation of
DEGs in the Rat Genome Database Disease Portals (RGD,
http://rgd.mcw.edu/wg/portals?100) was used to detect
the genes related to arterial hypertension and renal dis-
eases. The DEGs encoding the transcription factors were
detected using the atlas of combinatorial transcriptional
regulation in mouse and man [83], GenBank (http://
www.ncbi.nlm.nih.gov/gene/), and Panther classification
system (http://www.pantherdb.org/) [84].
Quantitative real-time PCR (qPCR)
To estimate the relative amount of target mRNA, qPCR
analysis was performed on the renal medulla samples
from ISIAH (n = 5) and WAG (n = 5) male rats aged as
3-month old. TRI reagent (Molecular research center,
USA) was used for the extraction of the total RNA, and
DNase I (Promega, USA) treatment was performed to
remove the residual genomic DNA. The kits were used
according to the manufacturer’s recommendations.
The protocol for the reverse transcription was the fol-
lowing: the reaction was carried out with 40 units of
MoMLV (Vektor-Best, Russia) in 50 μl of reaction mix-
ture, which contained reverse transcription (RT) buffer,
0.4 mM dNTPs, 0.25 nmol of random nonanucleotide
primers (Biosan, Russia), and 3 μg of total RNA. The
cDNA synthesis was performed at 37 °C (1 h), 42 °C
(30 min), and 50 °C (10 min) with the following inactiva-
tion of the enzyme by heating at 75 °C for 5 min.
The reaction volume for qPCR was 20 μl. It contained
a master mix with SYBR Green, 0.15 mM of each for-
ward and reverse primers, 1 unit of HotStart Taq poly-
merase (Vektor-Best, Russia), and the cDNA template.
The Rpl30 (ribosomal protein L30) stably expressed in
different tissues from ISIAH and WAG rats was used as
a reference gene. The primers sequences and character-
istics are given in Additional file 8.
qPCR was performed in an iCycler iQ4 Real-Time
PCR Detection System (Bio-Rad Laboratories, USA)
using the protocol described earlier [9]. Relative tran-
script levels were determined by standard-curve quanti-
tation method [85]. The mixture of the aliquots from all
synthesized cDNA samples was used as a standard
cDNA for calibration curves plotting. The value ob-
tained for the target gene was normalized against the
value for reference gene and then the relative mRNA
abundance was calculated as a ratio of the normalized
mRNA level in the experimental ISIAH samples to the
normalized mRNA level in the samples from WAG rats.
A value of 1 was assigned to the normalized mRNA level
obtained for the samples from control WAG rats.
Statistical methods
Mann-Whitney U-test (Statistica v.8.0, Statsoft, USA) was
used for calculations of the statistical significance for
qPCR data. Statistical significance was set at p < 0.05. The
data were expressed as M ± S.E.M. (means and their
standard errors).
The acquired RNA-seq data (FPKM values) were log
transformed, centered and normalized to run the partial-
least squares discriminant analysis (PLS-DA). First, the scal-
ing of the data sets was performed using principal coordi-
nates method based on Euclidean metric distances. Then,
the pattern of co-variation for linear combinations between
two blocks of variables [86] was explored to get the separ-
ation of groups in PLS-DA. PLS-DA and the following cal-
culation of Pearson correlation coefficients were performed
to find a set of variables (expressed genes) that maximize
the covariance between gene expression in ISIAH and
WAG rat strains and fixed dummy matrix representing
group membership [86] for WAG and ISIAH rats, corres-
pondingly. As a result of these procedures the PLS-DA
Axes maximizing the distances between hypertensive and
normotensive rats were constructed, the correlation be-
tween gene expression and PLS-DA Axis 1 was calculated,
and the genes contributing the most to differences between
ISIAH and WAG transcriptomes were revealed.
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